guo y et al. eur j cancer 2021 18 156:35-45

guo y et al. eur j cancer 2021 18 156:35-45

guo y et al. eur j cancer 2021 18 156:35-45, lai z et al. eur j cancer. 2022 oct 174:68-77, levine m et al. eur j cancer. 1993 29:34-43, sung et al. ca cancer j clin. 2021, eur j cancer. 2021 feb 144:232-241, eur j cancer 42:50-54 2006, int j cancer. 2015 oct 1 137 7 :1643-51, romaniello d et al. cancer. 2020 12 9 : 2394, ca cancer j clin. 2021 71 3 :209-249, eur j cancer if, ca cancer j clin. 2021 71:209-249, impact factor eur j cancer, zhang w et al. clin oncol 2021 39:e16173, eur j cancer impact factor 2023, m. zaoui et al. cancers 2019 11 2012, ca cancer j clin. 2022 72 2 : 165-182, european journal of cancer 169 2022 42-53, european journal of cancer author guidelines

guo y et al. eur j cancer 2021 18 156:35-45. There are any references about guo y et al. eur j cancer 2021 18 156:35-45 in here. you can look below.

guo y et al. eur j cancer 2021 18 156:35-45
guo y et al. eur j cancer 2021 18 156:35-45

guo y et al. eur j cancer 2021 18 156:35-45


lai z et al. eur j cancer. 2022 oct 174:68-77
lai z et al. eur j cancer. 2022 oct 174:68-77

lai z et al. eur j cancer. 2022 oct 174:68-77


levine m et al. eur j cancer. 1993 29:34-43
levine m et al. eur j cancer. 1993 29:34-43

levine m et al. eur j cancer. 1993 29:34-43


sung et al. ca cancer j clin. 2021
sung et al. ca cancer j clin. 2021

sung et al. ca cancer j clin. 2021


eur j cancer. 2021 feb 144:232-241
eur j cancer. 2021 feb 144:232-241

eur j cancer. 2021 feb 144:232-241


eur j cancer 42:50-54 2006
eur j cancer 42:50-54 2006

eur j cancer 42:50-54 2006


int j cancer. 2015 oct 1 137 7 :1643-51
int j cancer. 2015 oct 1 137 7 :1643-51

int j cancer. 2015 oct 1 137 7 :1643-51


romaniello d et al. cancer. 2020 12 9 : 2394
romaniello d et al. cancer. 2020 12 9 : 2394

romaniello d et al. cancer. 2020 12 9 : 2394


ca cancer j clin. 2021 71 3 :209-249
ca cancer j clin. 2021 71 3 :209-249

ca cancer j clin. 2021 71 3 :209-249


eur j cancer if
eur j cancer if

eur j cancer if


ca cancer j clin. 2021 71:209-249
ca cancer j clin. 2021 71:209-249

ca cancer j clin. 2021 71:209-249


impact factor eur j cancer
impact factor eur j cancer

impact factor eur j cancer


zhang w et al. clin oncol 2021 39:e16173
zhang w et al. clin oncol 2021 39:e16173

zhang w et al. clin oncol 2021 39:e16173


eur j cancer impact factor 2023
eur j cancer impact factor 2023

eur j cancer impact factor 2023


m. zaoui et al. cancers 2019 11 2012
m. zaoui et al. cancers 2019 11 2012

m. zaoui et al. cancers 2019 11 2012


ca cancer j clin. 2022 72 2 : 165-182
ca cancer j clin. 2022 72 2 : 165-182

ca cancer j clin. 2022 72 2 : 165-182


european journal of cancer 169 2022 42-53
european journal of cancer 169 2022 42-53

european journal of cancer 169 2022 42-53


european journal of cancer author guidelines
european journal of cancer author guidelines

european journal of cancer author guidelines


guo y et al. eur j cancer 2021 18 156:35-45, lai z et al. eur j cancer. 2022 oct 174:68-77, levine m et al. eur j cancer. 1993 29:34-43, sung et al. ca cancer j clin. 2021, eur j cancer. 2021 feb 144:232-241, eur j cancer 42:50-54 2006, int j cancer. 2015 oct 1 137 7 :1643-51, romaniello d et al. cancer. 2020 12 9 : 2394, ca cancer j clin. 2021 71 3 :209-249, eur j cancer if, ca cancer j clin. 2021 71:209-249, impact factor eur j cancer, zhang w et al. clin oncol 2021 39:e16173, eur j cancer impact factor 2023, m. zaoui et al. cancers 2019 11 2012, ca cancer j clin. 2022 72 2 : 165-182, european journal of cancer 169 2022 42-53, european journal of cancer author guidelines

AE AL AS AT BE BG BS BY CA CF CH CI CL BW ID IL IN JP MA NZ TH UK VE ZA AG AU BD BH BR BZ CO DO EC EG ET HK JM KH KW MT MX MY NG PE PE PK PR SA SG SV TR TW UA UY VN COM CZ DE DK DZ EE ES FI FM FM FR GR HN HR HU IE IS IT KG KZ LA LI LU LV MS NL NU PL PT RO RU SH SI SK SN TG TN TT